565 results on '"Smit, Jennifer"'
Search Results
2. Access to and acceptability of sexual and reproductive health, harm reduction and other essential health services among people who inject drugs in Durban, South Africa
3. Self-reported removal and expulsion of the dapivirine vaginal ring: qualitative reports from female ring users and their male partners in the Ring Study (IPM 027)
4. Teclistamab versus real-world physicians choice of therapy in triple-class exposed relapsed/refractory multiple myeloma.
5. Oral preexposure prophylaxis uptake, adherence, and persistence during periconception periods among women in South Africa
6. Comparative Effectiveness of Teclistamab Versus Real-World Physician’s Choice of Therapy in LocoMMotion and MoMMent in Triple-Class Exposed Relapsed/Refractory Multiple Myeloma
7. High Levels of Pretreatment HIV-1 Drug Resistance Mutations Among South African Women Who Acquired HIV During a Prospective Study
8. Sexually Transmitted Infection Prevalence, Partner Notification, and Human Immunodeficiency Virus Risk Perception in a Cohort of Women Completing Sexually Transmitted Infection Screening as Part of a Safer Conception Study
9. STI prevalence, partner notification and HIV risk perception in a cohort of women completing STI screening as part of a safer conception study
10. A continuum of individual-level factors that influence modern contraceptive uptake and use: perspectives from community members and healthcare providers in Durban, South Africa
11. “I am scared, I do not want to lie”: exploring the impacts of COVID-19 on engagement in care, perceived health, relationship dynamics, and parenting among postpartum women with HIV in South Africa
12. Perspectives on sexual and reproductive health self-care among women, healthcare providers, and other key informants: a mixed-methods study in South Africa and Zambia
13. Comparative Efficacy of Teclistamab Versus Current Treatments in Real-World Clinical Practice in the Prospective LocoMMotion Study in Patients with Triple-Class-Exposed Relapsed and/or Refractory Multiple Myeloma
14. Influences on PrEP Uptake and Adherence Among South African Women During Periconception and Pregnancy: A Qualitative Analysis
15. Comparative Efficacy of Teclistamab Versus Physician's Choice of Therapy in the Long-term Follow-up of APOLLO, POLLUX, CASTOR, and EQUULEUS Clinical Trials in Patients With Triple-class Exposed Relapsed or Refractory Multiple Myeloma
16. Performance and Acceptability of the FC2 Female Condom When Used With and Without a Silicone Placebo Vaginal Ring—A Randomized, Crossover Trial
17. Performance of Male Condoms When Used With and Without a Silicone Placebo Vaginal Ring—A Randomized, Crossover Trial
18. Trajectories of initiation for the heroin-based drug whoonga – qualitative evidence from South Africa
19. Is long‐acting reversible contraceptive method use associated with HIV testing frequency in KwaZulu‐Natal, South Africa and Lusaka, Zambia? Findings from the CUBE study
20. Translational Modeling Predicts Efficacious Therapeutic Dosing Range of Teclistamab for Multiple Myeloma
21. Consensus recommendations for measuring the impact of contraception on the menstrual cycle in contraceptive clinical trials
22. Contraceptive method preference and reasons for contraceptive discontinuation among women randomized to intramuscular depot medroxyprogesterone acetate, a copper intrauterine device or a levonorgestrel implant: Findings from Durban, South Africa
23. How is Clinical Trial Reimbursement Money Spent? South African Trial Participants’ Reported Reimbursement Spending Patterns and Perceptions of Appropriate Reimbursement Amounts
24. Acceptability of an Intervention to Promote Viral Suppression and Serostatus Disclosure for Men Living with HIV in South Africa: Qualitative Findings
25. Women's contraceptive choice following the use of Implanon NXT : Findings from a study in Durban, South Africa
26. Overcoming Ethical Challenges to Engaging Men Who Have Sex with Women in HIV Research
27. Incorporating oral PrEP into standard prevention services for South African women: a nested interrupted time-series study
28. Trajectories of initiation for the heroin-based drug whoonga – qualitative evidence from South Africa
29. PA-309 Comparing the accuracy of inflammation detection using the lateral flow point of care Genital InFlammation Test (GIFT) interpreted by visual inspection versus automated reader
30. Prevalence and incidence of sexually transmitted infections among South African women initiating injectable and long-acting contraceptives
31. Adherence to daily, oral TDF/FTC PrEP during periconception among HIV-exposed South African women
32. Community and Provider Perspectives on Addressing Unmet Need for Contraception : Key Findings from a Formative Phase Research in Kenya, South Africa and Zambia (2015-2016)
33. Quality of care in public sector family planning services in KwaZulu-Natal, South Africa: a qualitative evaluation from community and health care provider perspectives
34. Fertility desires of people living with HIV: does the implementation of a sexual and reproductive health and HIV integration model change healthcare providers’ attitudes and clients’ desires?
35. Integrating oral PrEP delivery among African women in a large HIV endpoint-driven clinical trial
36. Breastfeeding Practices Among Women Living with HIV in KwaZulu-Natal, South Africa: An Observational Study
37. Correction: Translational Modeling Predicts Efficacious Therapeutic Dosing Range of Teclistamab for Multiple Myeloma
38. Lubrication and Vaginal Sex: Lubricant Use and Preferences in General Population Women and Women at Risk of HIV
39. Sexual Relationship Power and Periconception HIV-Risk Behavior Among HIV-Infected Men in Serodifferent Relationships
40. Teclistamab: Mechanism of action, clinical, and translational science.
41. P979: PATIENT-REPORTED OUTCOMES FOR TECLISTAMAB VERSUS REAL-WORLD PHYSICIAN’S CHOICE OF THERAPY IN THE LOCOMMOTION STUDY IN PATIENTS WITH TRIPLE-CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA
42. Sexual Self-Efficacy and Gender : A Review of Condom Use and Sexual Negotiation Among Young Men and Women in Sub-Saharan Africa
43. Age-specific risk scores do not improve HIV-1 prediction among women in South Africa
44. HIV Prevention Among Young Women in South Africa: Understanding Multiple Layers of Risk
45. Missed Opportunities: Emergency Contraception Utilisation by Young South African Women
46. High risk injection drug use and uptake of HIV prevention and treatment services among people who inject drugs in KwaZulu-Natal, South Africa
47. Dual Protection against Sexually Transmitted Infections and Pregnancy in South Africa
48. Where Is the Condom? Contraceptive Practice in a Rural District of South Africa
49. “As we have gathered with a common problem, so we seek a solution”: exploring the dynamics of a community dialogue process to encourage community participation in family planning/contraceptive programmes
50. Client and provider knowledge and views on safer conception for people living with HIV (PLHIV)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.